Status:
COMPLETED
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Lead Sponsor:
Daniel Benjamin
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
The Emmes Company, LLC
Conditions:
Adenovirus
Anesthesia
Eligibility:
All Genders
Up to 21 years
Brief Summary
Understudied drugs will be administered to children per standard of care as prescribed by their treating caregiver and only biological sample collection during the time of drug administration will be ...
Detailed Description
The purpose of this study is to characterize the PK ( Pharmacokinetics) of understudied drugs administered to children per standard of care as prescribed by their treating caregiver. This will be acco...
Eligibility Criteria
Inclusion
- 1\) Children (\< 21 years of age) who are receiving understudied drugs of interest per standard of care as prescribed by their treating caregiver
Exclusion
- 1\) Failure to obtain consent/assent (as indicated)
- 2\) Known pregnancy as determined via interview or testing if available.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2019
Estimated Enrollment :
3520 Patients enrolled
Trial Details
Trial ID
NCT01431326
Start Date
November 1 2011
End Date
November 1 2019
Last Update
September 6 2023
Active Locations (52)
Enter a location and click search to find clinical trials sorted by distance.
1
Alaska Native Medical Center
Anchorage, Alaska, United States, 99508
2
Arkansas Children's Hospital
Little Rock, Arkansas, United States, 72202
3
University of California at San Diego Medical Center
La Jolla, California, United States, 92093
4
Axis Clinical Trials
Los Angeles, California, United States, 90036